Quanterix Corporation (QTRX) Dividend History

Company News

• New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

  The article discusses the growing cancer treatment market, with a focus on companies like Oncolytics Biotech, Akoya Biosciences, Quanterix, TScan Therapeutics, and Arcellx. It highlights new data and collaborations that signal a turning point for precision-driven cancer biotechs.

  Benzinga

  Featured Companies: ACLX AKYA ONCY TCRX
• $HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AKYA, WTMA, PLYA, QTRX to Act Now

  Monteverde & Associates PC, a class action law firm, is investigating several proposed mergers, including Akoya Biosciences' merger with Quanterix, Welsbach Technology Metals Acquisition's merger with Evolution Metals LLC, and Playa Hotels & Resorts' merger with Hyatt Hotels Corporation.

  GlobeNewswire Inc.

  Featured Companies: AKYA H PLYA
• Wall Street Analysts Believe Quanterix (QTRX) Could Rally 67.66%: Here's is How to Trade

  The consensus price target hints at a 67.7% upside potential for Quanterix (QTRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  Zacks Investment Research
• AI fever and elevated demand raise the bar for Nvidia margin expectations

  Nvidia's stock made it to the conviction list of one Wall Street firm, while another forecast the chip maker's next-generation tech could drop early.

  MarketWatch

  Featured Companies: AMD AMZN COMP CRM GOOG GOOGL INTC JCI MSFT NVDA OKTA